Paying with stock beats paying with cash when your shares are priced at or above their value, cash or debt is scarce, and the seller wants the upside. As of October 2026, the best recent evidence is a study of more than 6,000 U.S. IPO registrations (1990 to 2024) by Davidson Heath and Christopher Mace. It found that among newly public firms, stock payers trailed cash payers by 20 to 30 percentage points over three to five years. That gap is an average for newly public firms, not a rule for every acquirer.
Stock tends to win in four situations. It tends to lose in one.
The test is the price of your shares against their value, not stock against cash in the abstract.
Three sources are worth knowing. Read each for what it measured.
Read the limits before you quote them.
My view is that the research supports caution, not a ban. Stock-paid deals struggle when the stock was the cheapest way to say yes to a high price.
Assumptions. A target is bought for $8,000,000. The acquirer's shares trade at $10.00. The deal is paid entirely in shares, so the acquirer issues 8,000,000 / 10 = 800,000 shares. The three cases differ only in what a share is really worth.
You rarely know the true worth of your shares. That is why valuing your own stock comes before the decision.
Under the Treasury regulation on continuity of interest, a target owner must keep a substantial part of the value in the buyer's stock for a deal to be treated as a tax-deferred reorganization. The regulation gives no single percentage in its text, but its examples treat a deal with 40 percent stock as preserving continuity and deals with 25 percent or less as not preserving it. A deal that falls short generally does not qualify as a tax-deferred reorganization. This is a question for the seller's tax advisor.
Where these numbers come from: The study of IPO registrations is from the CLS Blue Sky Blog (Heath and Mace, July 14, 2026). Loughran and Vijh are from the Loughran and Vijh (1997) abstract, RePEc. Berkshire's stance is from its Berkshire Hathaway 1983 shareholder letter. The continuity-of-interest examples are from 26 CFR 1.368-1 (Cornell LII copy). The $8,000,000 price, the $10.00 share price and the three value cases are assumptions. Confirm tax treatment with a tax advisor.
No. The study measured newly public firms, and the gap is an average over three to five years. It is a warning about habit, not a rule about one deal.
No. Cash paid with borrowed money adds fixed payments. Stock adds no payments but dilutes holders. Neither is safe if the price is wrong.
Yes. Many deals are. A mix lowers dilution and still gives the seller a stake. See what rollover equity is and how much is typical.
To test whether your own shares are a fair price to pay, see how you value your own stock when using it to buy a company.
Meraki Dealmakers is a service of Meraki Partners, LLC, an advisory firm. It is not a broker-dealer, investment adviser, business broker, law firm or accounting firm. This article is general information, not legal, tax or investment advice.
Start with the playbook. The first conversation is free.
Meraki Dealmakers is a service of Meraki Partners, LLC.
Meraki Partners, LLC is an advisory firm. It is not a broker-dealer, investment adviser, business broker, law firm or accounting firm, and does not solicit investors or receive compensation based on capital raised.
© 2026 Meraki Partners, LLC